Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques.

Athanasios Katsargyris (Erstautor/-in), Stamatios E Theocharis, Sotirios Tsiodras, Konstantinos Giaginis, Elias Bastounis, Chris Klonaris

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

15 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	10
Fachzeitschrift	EXPERT OPINION ON THERAPEUTIC TARGETS
Jahrgang	14
Ausgabenummer	1
DOIs	https://doi.org/10.1517/14728220903401294
Publikationsstatus	Veröffentlicht - 2010

Zugriff auf Dokument

10.1517/14728220903401294

Dieses zitieren

@article{9022880f3ec744c89e22d619d45628c8,

title = "Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques.",

keywords = "TOLL-LIKE RECEPTOR-4, ACUTE CORONARY SYNDROME, C-REACTIVE PROTEIN, NF-KAPPA-B, INFLAMMATORY DISEASE, ARTERY STENOSIS, DENDRITIC CELLS, INNATE IMMUNITY, RISK-FACTOR, TOLL-LIKE-RECEPTOR-4",

author = "Athanasios Katsargyris and Theocharis, {Stamatios E} and Sotirios Tsiodras and Konstantinos Giaginis and Elias Bastounis and Chris Klonaris",

year = "2010",

doi = "10.1517/14728220903401294",

language = "English",

volume = "14",

pages = "10",

journal = "EXPERT OPINION ON THERAPEUTIC TARGETS",

issn = "1472-8222",

number = "1",

}

TY - JOUR

T1 - Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques.

AU - Katsargyris, Athanasios

AU - Theocharis, Stamatios E

AU - Tsiodras, Sotirios

AU - Giaginis, Konstantinos

AU - Bastounis, Elias

AU - Klonaris, Chris

PY - 2010

Y1 - 2010

KW - TOLL-LIKE RECEPTOR-4

KW - ACUTE CORONARY SYNDROME

KW - C-REACTIVE PROTEIN

KW - NF-KAPPA-B

KW - INFLAMMATORY DISEASE

KW - ARTERY STENOSIS

KW - DENDRITIC CELLS

KW - INNATE IMMUNITY

KW - RISK-FACTOR

KW - TOLL-LIKE-RECEPTOR-4

U2 - 10.1517/14728220903401294

DO - 10.1517/14728220903401294

M3 - Original Article

C2 - 20001205

SN - 1472-8222

VL - 14

SP - 10

JO - EXPERT OPINION ON THERAPEUTIC TARGETS

JF - EXPERT OPINION ON THERAPEUTIC TARGETS

IS - 1

ER -